Investor Relations

IR Home

Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$15.72
Change (%) Stock is Up 0.46 (3.01%)
Volume1,008,712
Data as of 08/30/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Latest Presentation
Download Documentation JMP Securities 2016 Life Sciences Conference Presentation
August 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-1123456
78910111213
14151617181920
21222324252627
28293031515253

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
08/30/16
USPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent
08/25/16
Vanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation
08/01/16
HETLIOZ® is Now Available for the Treatment of Non-24-Hour Sleep-Wake Disorder in Germany
More >>
Upcoming Events
There are currently no events scheduled.
More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2007 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy